Cortexin administration due to improvement of cognitive and behavioral disorders in children and teenagers with epilepsy
V Kalmykova G, Chefranova ZY, Rybnikova VF, Zubova KO · 2021 · Zh Nevrol Psikhiatr Im S S Korsakova 121(3):127-131. PMID 33834730
What does this source report?
Adjunctive treatment report describes cognitive and electrophysiological changes; absence of seizure aggravation was reported in 95%.
- Population and setting
- 86 children and adolescents with epilepsy
- Evidence type
- Uncontrolled human report
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- That observation is not proof of seizure safety; no randomized untreated comparator described.
- Pediatric clinical findings do not establish enhancement or safety in healthy adults.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: V Kalmykova G, Chefranova ZY, Rybnikova VF, Zubova KO. Cortexin administration due to improvement of cognitive and behavioral disorders in children and teenagers with epilepsy Zh Nevrol Psikhiatr Im S S Korsakova 121(3):127-131. PMID 33834730 2021.
Molekul research summary: https://molekul.io/research/bio-33834730. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry